首页> 外文期刊>Science Advances >Facile profiling of molecular heterogeneity by microfluidic digital melt
【24h】

Facile profiling of molecular heterogeneity by microfluidic digital melt

机译:通过微流数字熔体轻松进行分子异质性分析

获取原文
           

摘要

This work presents a digital microfluidic platform called HYPER-Melt (high-density profiling and enumeration by melt) for highly parallelized copy-by-copy DNA molecular profiling. HYPER-Melt provides a facile means of detecting and assessing sequence variations of thousands of individual DNA molecules through digitization in a nanowell microchip array, allowing amplification and interrogation of individual template molecules by detecting HRM fluorescence changes due to sequence-dependent denaturation. As a model application, HYPER-Melt is used here for the detection and assessment of intermolecular heterogeneity of DNA methylation within the promoters of classical tumor suppressor genes. The capabilities of this platform are validated through serial dilutions of mixed epialleles, with demonstrated detection limits as low as 1 methylated variant in 2 million unmethylated templates (0.00005%) of a classic tumor suppressor gene, CDKN2A (p14ARF). The clinical potential of the platform is demonstrated using a digital assay for NDRG4, a tumor suppressor gene that is commonly methylated in colorectal cancer, in liquid biopsies of healthy and colorectal cancer patients. Overall, the platform provides the depth of information, simplicity of use, and single-molecule sensitivity necessary for rapid assessment of intermolecular variation contributing to genetic and epigenetic heterogeneity for challenging applications in embryogenesis, carcinogenesis, and rare biomarker detection.
机译:这项工作提出了一种称为HYPER-Melt(高密度分析和熔体枚举)的数字微流体平台,用于高度并行的逐拷贝DNA分子分析。 HYPER-Melt提供了一种简便的方法,可以通过在纳米孔微芯片阵列中进行数字化来检测和评估成千上万个单个DNA分子的序列变异,从而可以通过检测由于序列依赖性变性而导致的HRM荧光变化来扩增和询问单个模板分子。作为模型应用,此处将HYPER-Melt用于检测和评估经典肿瘤抑制基因启动子内DNA甲基化的分子间异质性。该平台的功能通过混合稀释的等位基因的连续稀释得到验证,在经典肿瘤抑制基因CDKN2A(p14ARF)的200万未甲基化模板中,已证明的检测限低至1个甲基化变体(0.00005%)。在健康和大肠癌患者的液体活检中,通过对NDRG4的数字化检测证明了该平台的临床潜力,NDRG4是在大肠癌中通常甲基化的抑癌基因。总体而言,该平台可提供信息深度,使用简便和快速评估分子间变异所必需的单分子敏感性,这些分子变异有助于遗传和表观遗传异质性,可在胚胎发生,致癌作用和稀有生物标志物检测中具有挑战性的应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号